Despite being 33 years old, Sahm Adrangi has made a name for himself in the financial industry. He is a private investment manager who operates his own business, Kerrisdale Capital Management, LLC. He is located in New York, New York and he has two focuses for his hedge fund. The first focus is on investing in long-term value investments. The second one is taking advantage of event-driven special situations. It is this latter focus which led him to short the stock of Proteostasis Therapeutics, Inc. and then release a negative report about this company.
Proteostasis Therapeutics is a firm which pretty much bases its entire value on one drug candidate, PTI-428. This drug is being evaluated for the treatment of cystic fibrosis. Their stock soared by 100% when PTI-428 was given both the Orphan Drug and Breakthrough Therapy designations by the Food and Drug Administration. However, Sahm Adrangi and his team presented their analysis that is drug is very likely ineffective. He issued a negative report indicating that Kerrisdale Capital saw a pattern of low-quality data in regard to this drug and some vital information was omitted from this company’s public disclosures.
Due to what he saw, Sahm Adrangi took a short position on this firm. This means that if their shares fall the fund he manages will make money. In his report he noted that he was going to have a conference call later that day where he and his team would go into more detail in what they discovered. This was held on March 20, 2018. at 10:30 a.m. ET. Anyone could call in and participate in this event.
Sahm Adrangi has been managing his investment firm since 2009. His company now manages $300 million which is mostly in value investments. He entered the financial industry in 2004 after graduating from Yale University. He worked as an analyst for a few different firms, such as Longacre Fund Management LLC, before deciding to open his own company. He was able to do so with his own money plus that of his family, friends, and other supporters.
Attracting and keeping talent is crucial in today’s market. Talented employees are vitally important. Many people who are able to bring something special to the table are also those who have many opportunities. Savvy and thoughtful company owners look for innovative ways to help make sure that all of their employees are happy with the terms and conditions of their employment. One person who knows this well is Jeremy Goldstein. Jeremy Goldstein has been working in the business field for decades. During this time, he has learned how to attract the best possible candidates to any business venture. He has also learned the best way to help keep them there. In a recent article, Jeremy Goldstein speaks out about one new way that company officials everywhere have been exploring. Stock options have been on the table when it comes to compensation for the very top levels of company management.
Advantages and Disadvantages
As Jeremy Goldstein points out, there are both advantages and disadvantages when it comes to providing stock options for employees and top brass. For example, over time, the value of any given stock may fall. When a stock falls, the stock’s owners may realize little if any value in compensation from owning a given stock. Instead of being rewarded for doing a really good job, a hard working employee may in fact be faced with a net loss that means they’ve earned very little from their devotion and hard work. They can also impose accounting burdens of the company. Company officials may need to devote a significant amount of time to managing the options they have chosen to grant their employees and top talent. On the other hand, Jeremy Goldstein also points out that a company official may also benefit greatly from having compensation in the form of stock options. Learn more: https://www.crunchbase.com/person/jeremy-goldstein#/entity
It is because he’s worked so hard that Jeremy Goldstein is able to offer the insights he does. Goldstein has an extensive background in the business world. As a highly valued partner in the respected firm of Jeremy L. Goldstein & Associates, LLC, he helps to run a unique boutique law firm that offers many important services to clients. As part of this role, he is a specialist in varied forms of corporate behavior and policy. He and his staff of internationally respected partners also specialize in specifics such as advising compensation committees. They also help with other specifics such as working closely with CEO’s and management teams in order to help determi executive compensation.